Brian J. Donnelly - 01 May 2025 Form 4 Insider Report for MYRIAD GENETICS INC (MYGN)

Reporting relationship: Chief Commerical Officer
Issuer ticker: MYGN
Reported as of: 01 May 2025
Net transaction value: $0
SEC form: 4
Accepted by SEC: 02 May 2025, 16:15:16 UTC
Next SEC filing: 16 Mar 2026
Source filing: View source filing
Reporting owner signature: By: Justin Hunter For: Brian J. Donnelly

Key filing fact

Brian J. Donnelly filed Form 4 for MYRIAD GENETICS INC (MYGN) on 02 May 2025.

Key facts

This page summarizes Brian J. Donnelly's Form 4 filing for MYRIAD GENETICS INC (MYGN).
3 reported transactions and 1 derivative row are listed below.
Accepted by SEC: 02 May 2025, 16:15.

Change

No earlier filing in this sequence is available for direct comparison.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0002065630 Primary reporting owner

Donnelly Brian J

Relationship: Chief Commerical Officer
Address: 322 NORTH 2200 WEST, SALT LAKE CITY
Signature: By: Justin Hunter For: Brian J. Donnelly
Signature date: 02 May 2025

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

MYGN transaction

Common Stock

Award

Transaction value: $0
Shares: +269,905
Change %
Price: $0.000000
Shares after: 269,905
Date: 01 May 2025
Ownership: Direct
Footnotes: F1

MYGN transaction

Common Stock

Award

Transaction value: $0
Shares: +127,629
Change %: +47%
Price: $0.000000
Shares after: 397,534
Date: 01 May 2025
Ownership: Direct
Footnotes: F2

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

MYGN transaction Derivative

Performance-Based Restricted Stock Units

Award

Transaction value: $0
Shares: +236,167
Change %
Price: $0.000000
Shares after: 236,167
Date: 01 May 2025
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 236,167
Exercise price
Footnotes: F3

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 3 footnotes

Footnote F1

Consists of time-based restricted stock units granted to the reporting person. Each restricted stock unit represents a contingent right to receive one share of the Company's common stock and vests in four equal annual installments beginning on the first anniversary of the grant date.

Footnote F2

Consists of time-based restricted stock units granted pursuant to the Company's 2017 Employee, Director and Consultant Equity Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of the Company's common stock and vests in three equal annual installments beginning on the first anniversary of the grant date.

Footnote F3

The shares subject to the performance-based restricted stock units ("PSUs") represent the maximum number of shares that may vest based on the Issuer's achievement of specified stock price milestones. The PSUs will vest upon certification by the Compensation and Human Capital Committee as to 25% of the shares upon the achievement of each of four stock price milestones, subject to the reporting person's continued employment or service through the applicable vesting date; provided; however, that no portion of the PSUs may vest earlier than May 1, 2026.